Cantargia utvecklar en antikroppsbaserad behandling riktad mot målmolekylen IL1RAP som har potential att användas för ett flertal olika cancersjukdomar.

Biotechnology

Cantargia

Göran Forsberg

Lars Thorsson

Ton Berkien

Patrik Renblad

David Liberg

Liselotte Larsson

Magnus Persson

Thoas Fioretos

Flavia Borellini

Magnus Nilsson

Damian Marron

Anders Martin-Löf

The Clinical Development Team at Cantargia is responsible for designing and overseeing clinical trials aimed at evaluating the safety and efficacy of the company's antibody-based treatment targeting IL1RAP in various cancer types. The team collaborates closely with regulatory bodies, manages project timelines, and ensures compliance with clinical standards, while integrating insights from preclinical research to drive advancements in therapeutic development.

Clinical Development Team

The Leadership Team at Cantargia is responsible for steering the strategic direction of the company, focusing on the development of antibody-based therapies targeting the IL1RAP molecule for various cancers. This team collaborates across research, clinical development, and operational functions to ensure effective execution of the company's goals while fostering innovation and driving growth in the biopharmaceutical sector.

Leadership Team

The Governance and Board Team at Cantargia is responsible for overseeing corporate governance practices, aligning the company's strategic direction with its mission to develop innovative antibody-based treatments targeting IL1RAP for various cancers. This team, consisting of experienced members, ensures compliance with regulations, provides strategic guidance, and supports effective decision-making to drive the company's success and enhance stakeholder value.

Governance and Board Team

The Biometrics and Research Team at Cantargia focuses on integrating advanced data analysis and bioinformatics to support the development of antibody-based therapies targeting IL1RAP. This team collaborates closely with research scientists to design and analyze clinical trials, ensuring robust data management and interpretation to drive scientific advancements in cancer treatment.

Biometrics and Research Team

The Finance and Operations Team at Cantargia is responsible for managing the company's financial health and operational efficiency. They oversee budgeting, financial reporting, and strategic planning to ensure resources are allocated effectively. Additionally, the team works to streamline operations, enabling the company to focus on developing its innovative antibody-based cancer treatments targeting IL1RAP.

Cantargia

Org chart

Board & advisors

Teams

Clinical Development Team

Leadership Team

Governance and Board Team

Biometrics and Research Team

Finance and Operations Team

Offices

Cantargia

Org chart

Board & advisors

Teams

Clinical Development Team

Leadership Team

Governance and Board Team

Biometrics and Research Team

Finance and Operations Team

Offices

Related companies